InspireMD (STU:II2) Tariff Resilience Score: 5/10 (As of Jul. 01, 2026)


STU:II2 InspireMD Inc STU:II2
42 GF Score
Price €0.61
GF Value €1.55
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Tariff Resilience Score?

InspireMD STU:II2 +1.67% 42 Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus rates STU:II2 with a GF Score™ of 42/100 and a GF Value™ of €1.55 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 838 Medical Devices & Instruments companies, InspireMD ranks better than 79.12% on this metric.

InspireMD has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

InspireMD has InspireMD relies on international suppliers for medical device components, exposing it to tariff risks. However, its global sales distribution helps mitigate some impact.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes InspireMD might have Average Resilient.

InspireMD  (STU:II2) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

InspireMD Tariff Resilience Score Related Terms

STU:II2 vs TELA, BDMD, PAVM: Tariff Resilience Score Comparison

For the Medical Devices subindustry, InspireMD's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where InspireMD's Tariff Resilience Score falls into.


STU:II2
42GF Score
InspireMD Inc STU:II2
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
InspireMD (STU:II2) has a Tariff Resilience Score of 5 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, InspireMD ranks #175 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 20.9%.
Is InspireMD's Tariff Resilience Score too high?
InspireMD's current Tariff Resilience Score is 5. Based on the distribution chart, InspireMD ranks #175 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InspireMD has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InspireMD's Tariff Resilience Score compare to TELA and BDMD?
According to the Medical Devices & Instruments industry distribution chart, InspireMD ranks #175 out of 838 companies for Tariff Resilience Score. This places InspireMD in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. InspireMD's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InspireMD stock overvalued right now?
Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.55, compared to a current price of €0.61 — trading 60.6% below its estimated fair value. The current Tariff Resilience Score is 5. InspireMD's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For InspireMD (STU:II2), the current Tariff Resilience Score is 5 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.61 is trading 60.6% below its estimated GF Value™ of €1.55. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

  • Tariff Resilience Score: 5
  • GF Value™: €1.55 vs. price of €0.61 (60.6% below fair value)
  • GF Score™: 42/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Other Exchanges NSPR:USA
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
42GF Score

Get the complete analysis for STU:II2

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.61
Price
€1.55
GF Value